擅长:熟练掌握泌尿外科及男科常见病、多发病的诊治,尤其擅长前列腺增生、前列腺炎、泌尿系结石、泌尿系肿瘤(前列腺癌、膀胱癌、肾癌、肾盂肿瘤、肾上腺肿瘤)、精索静脉曲张及阳痿早泄等疾病的诊治。
荣获奖项:荣获2021年度“高新区优秀医师”称号
发表文章:
(1)Peng Zhang1, Xiaodong Tan2, Daoqiang Zhang3, Qi Gong3, Xuefeng Zhang1,*. Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysis. PLOS ONE (影响因子:3.242). 2021 May 4;16(5):e0249951. doi: 10.1371/journal.pone.0249951. PMID: 33945533; PMCID: PMC8096091.
(2)Peng Zhang1, Chengyi Liu2, Yantao Lou1, Xuefeng Zhang3, Zhihong Zhang1*, Changwen Zhang1*. ITGAX Has Potential to Be a Prognostic Marker in Tumor microenvironmental remodeling for Prostate Cancer: A Study Based on TCGA Database. Front Genet (影响因子:4.592). 2021(The first revision has been completed)
(3) Peng Zhang1, Zesheng An1, Xuefeng Zhang2, Zhihong Zhang1*, Yong Xu1*. FLG gene mutation up-regulates the abnormal tumor immune response and promotes the progression of prostate cancer.Curr Pharm Biotechnol(影响因:2.834).2021.(in peer review)
(4) Peng Zhang1, Aiyu Wang2, Daoqiang Zhang3, Qi Gong3, Xuefeng Zhang1,*. Development of a potential 7 immune-gene-based nomogram and key gene INSL5 associated with the pathogenesis and prognosis of prostate cancer. BMC Cancer(影响因子:3.15). 2021(in peer review)
(5)张鹏; 董礼明; 张学峰; 于永泉;李英明;邱江英;董礼明*;抗中性粒细胞胞浆抗体相关性血管炎致自发性肾破裂一例报告,中华泌尿外科杂志,2017,38(12):947-948.
(6)张鹏; 李军涛; 路西兰; 王恒才*;精子上游器的研制及其实验效果,中国性科学,2014,23(05):25-27.
(7)李慧,张鹏,张学峰. 腹腔镜下输尿管膀胱再植术治疗医源性输尿管损伤6例临床分析[J]. 中国实用医药,2017,12(20):87-88. DOI:10.14163/j.cnki.11-5547/r.2017.20.045.
联系电话: 13696310683
微信号:13696310683
电子邮箱:pengzhangdoctor@hotmail.com